Implantation underneath the abdominal anterior rectus sheath enables effective and functional engraftment of stem-cell-derived islets
Zhen Liang,Dong Sun,Shuaiyao Lu,Zhengjun Lei,Shusen Wang,Zhifeng Luo,Jinqin Zhan,Shuangshuang Wu,Yong Jiang,Zhi Lu,Shicheng Sun,Yingying Shi,Haiting Long,Yanling Wei,Wenhai Yu,Zhihui Wang,Liew Soon Yi,Yun Zhang,Wenyong Sun,Xiaofeng Fang,Yanyan Li,Sufang Lu,Jiayun Lv,Weiguo Sui,Zhongyang Shen,Xiaozhong Peng,Yuanyuan Du,Hongkui Deng
DOI: https://doi.org/10.1038/s42255-022-00713-7
Abstract:Human pluripotent stem cell-derived islets (hPSC islets) are a promising alternative to primary human islets for the treatment of insulin-deficient diabetes. We previously demonstrated the feasibility of this approach in nonhuman primates; however, the therapeutic effects of hPSC islets can be limited by the maladaptive processes at the transplantation site. Here, we demonstrate successful implantation of hPSC-derived islets in a new transplantation site in the abdomen, the subanterior rectus sheath, in eight nonhuman primates (five male and three female). In this proof-of-principle study, we find that hPSC islets survive and gradually mature after transplantation, leading to improved glycemic control in diabetic primates. Notably, C-peptide secretion responds to meal challenge from 6 weeks post-transplantation (wpt), with stimulation indices comparable to those of native islets. The average post-prandial C-peptide level reaches approximately 2.0 ng ml-1 from 8 wpt, which is five times higher than the peak value we previously obtained after portal vein infusion of hPSC islets and was associated with a decrease of glycated hemoglobin levels by 44% at 12 wpt. Although additional studies in larger cohorts involving long-term follow-up of transplants are needed, our results indicate that the subanterior rectus sheath supports functional maturation and maintenance of hPSC islets, suggesting that it warrants further exploration as a transplantation target site in the context of for hPSC-based cell-replacement therapies.